Home › Trials › NCT06981156
Clinical trial Recruiting at 1 site Observational Ages 1 Year to 17

Evaluating a Neurologic Assessment Scale for Pediatric Brain and Spine Tumors

Official title: Evaluation of the Neurologic Assessment in Pediatric Neuro-Oncology (pNANO)

Run by University of Wisconsin, Madison · NCT06981156 · Data updated 2026-11-12

This study is testing a new neurologic exam scale for kids with brain and spine tumors to see how consistently different doctors can use it to check their progress, including doing some assessments through telemedicine.

More Pediatric Brain Tumor trials

Quick facts

Study typeObservational
Ages1 Year to 17 Years
SexAll
Enrollment252 (estimated)
SponsorUniversity of Wisconsin, Madison
Academic / other
Drugs / interventionsradiation
Locations1 site (Madison, Wisconsin)
StatusRecruiting
StartedMay 13, 2025
Main results expectedJanuary 2027
Study endsJanuary 2027
Registry record updatedJuly 21, 2026
Trial IDNCT06981156 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include pediatric patients aged 1 year and older with confirmed brain or spine tumors who are being seen in a pediatric clinic.

Probably not a fit

Patients without a confirmed diagnosis of a brain or spine tumor or those who cannot provide informed consent may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the inter-observer variability of the pNANO scale, a neurologic exam scale designed for pediatric patients with brain and spinal cord tumors. During routine clinic visits, neurologic examinations will be conducted by multiple independent providers to ensure objective assessment of tumor response. Each provider will document their findings on the pNANO scale without communicating with one another, allowing for a blinded evaluation. The study will also explore the feasibility of conducting these assessments via telemedicine for a subset of participants.

Why it matters

Potential benefit: If successful, this study could lead to a more standardized and objective method for assessing tumor response in pediatric patients, improving treatment monitoring.

How similar studies have gone: While the pNANO scale is a novel approach, similar studies assessing inter-observer variability in clinical evaluations have shown promise in improving assessment accuracy.

Who can join: the full rules

Show full inclusion / exclusion criteria 
Inclusion Criteria:

* greater than or equal to 1 year old
* must be seen in the pediatric clinic
* Radiographic or histologic confirmation of a brain or spine tumor at the time of initial diagnosis
* Patient or parent/guardian must be able to understand the consent and be willing to sign a written informed consent document according to institutional guidelines.

Exclusion Criteria:

* none specified

Where it's running

  • American Family Children's Hospital
    Madison, Wisconsin, United States     Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
View on ClinicalTrials.gov ↗ Find more trials like this →
Browse more
Pediatric Brain Tumor 8University of Wisconsin-Madison 1471
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.